# Axogen, Inc.: Form 8-K/A, filed Sep 10, 2026

- Company: [Axogen, Inc.](/companies/axgn.md) (CIK 805928)
- Form: 8-K/A
- Filed: 2026-09-10
- Accepted by EDGAR: Sep 10, 2026, 16:55 ET
- Period: 2026-09-09
- Accession: 0001628280-26-061393
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/axgn-20260909.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/axgn-20260909.htm

Filed Sep 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-061393. Last ingested by Listed: Oct 28, 2026, 07:05 ET. No prices; not investment advice.
